ENDRA LIFE SCIENCES INC. Operating Lease, Right-of-Use Asset, Amortization Expense
ENDRA LIFE SCIENCES INC. (NDRA) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $61.23 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-14
- ENDRA LIFE SCIENCES INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $31.01K, a 32.32% increase year-over-year.
- ENDRA LIFE SCIENCES INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $30.22K, a 4.95% decline year-over-year.
- ENDRA LIFE SCIENCES INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $29.41K, a 16.82% decline year-over-year.
- ENDRA LIFE SCIENCES INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $28.60K, a 32.72% decline year-over-year.
- ENDRA LIFE SCIENCES INC. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $113.25K, a 29.08% decline from fiscal 2024.
- ENDRA LIFE SCIENCES INC. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $159.68K, a 5.25% increase from fiscal 2023.
- ENDRA LIFE SCIENCES INC. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $151.72K, a 10.27% increase from fiscal 2022.
- ENDRA LIFE SCIENCES INC. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $137.60K, a 27.20% increase from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $31.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $61.23K 10-Q · filed 2026-08-14 | $90.65K derived: sum of 3 quarters · filed 2026-08-14 | $119.25K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $30.22K 10-Q · filed 2026-05-15 | $59.64K derived: sum of 2 quarters · filed 2026-05-15 | $88.24K derived: sum of 3 quarters · filed 2026-05-15 | $111.67K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $29.41K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $58.02K derived: sum of 2 quarters · filed 2026-03-31 | $81.45K derived: sum of 3 quarters · filed 2026-08-14 | $113.25K 10-K · filed 2026-03-31 |
| 2025-09-30 | $28.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $52.04K derived: sum of 2 quarters · filed 2026-08-14 | $83.83K 10-Q · filed 2025-11-14 | $119.20K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $23.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $55.23K 10-Q · filed 2026-08-14 | $90.59K derived: sum of 3 quarters · filed 2026-08-14 | $133.11K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $31.80K 10-Q · filed 2026-05-15 | $67.16K derived: sum of 2 quarters · filed 2026-05-15 | $109.67K derived: sum of 3 quarters · filed 2026-05-15 | $151.10K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $35.36K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $77.88K derived: sum of 2 quarters · filed 2026-03-31 | $119.31K derived: sum of 3 quarters · filed 2026-03-31 | $159.68K 10-K · filed 2026-03-31 |
| 2024-09-30 | $42.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $83.94K derived: sum of 2 quarters · filed 2025-11-14 | $124.32K 10-Q · filed 2025-11-14 | $163.68K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $41.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $81.81K 10-Q · filed 2025-08-14 | $121.17K derived: sum of 3 quarters · filed 2025-08-14 | $159.56K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $40.38K 10-Q · filed 2025-05-15 | $79.74K derived: sum of 2 quarters · filed 2025-05-15 | $118.13K derived: sum of 3 quarters · filed 2025-05-15 | $155.57K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $39.36K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-04-07 | $77.75K derived: sum of 2 quarters · filed 2025-04-07 | $115.20K derived: sum of 3 quarters · filed 2025-04-07 | $151.72K 10-K/A · filed 2025-04-07 |
| 2023-09-30 | $38.39K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-11-21 | $75.84K derived: sum of 2 quarters · filed 2024-11-21 | $112.36K 10-Q/A · filed 2024-11-21 | $148.00K derived: sum of 4 quarters · filed 2024-11-21 |
| 2023-06-30 | $37.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $73.97K 10-Q · filed 2024-08-14 | $109.61K derived: sum of 3 quarters · filed 2024-08-14 | $144.41K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $36.53K 10-Q · filed 2024-05-14 | $72.17K derived: sum of 2 quarters · filed 2024-05-14 | $106.97K derived: sum of 3 quarters · filed 2024-05-14 | $140.94K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $35.64K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $70.44K derived: sum of 2 quarters · filed 2024-03-28 | $104.42K derived: sum of 3 quarters · filed 2024-03-28 | $137.60K 10-K · filed 2024-03-28 |
| 2022-09-30 | $34.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $68.78K derived: sum of 2 quarters · filed 2023-11-14 | $101.96K 10-Q · filed 2023-11-14 | $134.37K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $33.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $67.16K 10-Q · filed 2023-08-14 | $99.57K derived: sum of 3 quarters · filed 2023-08-14 | $131.25K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $33.18K 10-Q · filed 2023-05-15 | $65.59K derived: sum of 2 quarters · filed 2023-05-15 | $97.27K derived: sum of 3 quarters · filed 2023-05-15 | $123.91K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $32.41K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $64.09K derived: sum of 2 quarters · filed 2023-03-16 | $90.73K derived: sum of 3 quarters · filed 2023-03-16 | $108.18K 10-K · filed 2023-03-16 |
| 2021-09-30 | $31.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $58.32K derived: sum of 2 quarters · filed 2022-11-14 | $75.77K 10-Q · filed 2022-11-14 | $92.82K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $26.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $44.09K 10-Q · filed 2022-08-15 | $61.13K derived: sum of 3 quarters · filed 2022-08-15 | $77.79K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $17.45K 10-Q · filed 2022-05-12 | $34.50K derived: sum of 2 quarters · filed 2022-05-12 | $51.16K derived: sum of 3 quarters · filed 2022-05-12 | $67.44K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $17.05K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $33.71K derived: sum of 2 quarters · filed 2022-03-30 | $49.99K derived: sum of 3 quarters · filed 2022-03-30 | $65.91K 10-K · filed 2022-03-30 |
| 2020-09-30 | $16.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $32.94K derived: sum of 2 quarters · filed 2021-11-15 | $48.86K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $16.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $32.20K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $15.91K 10-Q · filed 2021-05-17 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $0.00 derived: sum of 2 quarters · filed 2020-11-16 | $0.00 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $0.00 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |